Rae JM - Search Results

1

Correction to: Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer.

Gonzalez TL, Hancock M, Sun S, Gersch CL, Larios JM, David W, Hu J, Hayes DF, Wang S, Rae JM. Gonzalez TL, et al. Among authors: rae jm. Breast Cancer Res Treat. 2020 Apr;180(3):623. doi: 10.1007/s10549-020-05594-6. Breast Cancer Res Treat. 2020. PMID: 32180072

2

Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine.

Stearns V, Johnson MD, Rae JM, Morocho A, Novielli A, Bhargava P, Hayes DF, Desta Z, Flockhart DA. Stearns V, et al. Among authors: rae jm. J Natl Cancer Inst. 2003 Dec 3;95(23):1758-64. doi: 10.1093/jnci/djg108. J Natl Cancer Inst. 2003. PMID: 14652237 Clinical Trial.

3

EGFR and EGFRvIII expression in primary breast cancer and cell lines.

Rae JM, Scheys JO, Clark KM, Chadwick RB, Kiefer MC, Lippman ME. Rae JM, et al. Breast Cancer Res Treat. 2004 Sep;87(1):87-95. doi: 10.1023/B:BREA.0000041585.26734.f9. Breast Cancer Res Treat. 2004. PMID: 15377854 Free article.

4

(-)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancer.

Xu L, Yang D, Wang S, Tang W, Liu M, Davis M, Chen J, Rae JM, Lawrence T, Lippman ME. Xu L, et al. Among authors: rae jm. Mol Cancer Ther. 2005 Feb;4(2):197-205. Mol Cancer Ther. 2005. PMID: 15713891

5

Consensus statement: Expedition Inspiration 2004 Breast Cancer Symposium 'Breast Cancer--The Development and Validation of New Therapeutics'.

Lippman ME, Benz C, Chinnaiyan A, Flockhart D, Harris A, Hudis C, Osborne CK, Press MF, Rae J, Sledge GW, Van't Veer L, Wicha M. Lippman ME, et al. Breast Cancer Res Treat. 2005 Mar;90(1):1-3. doi: 10.1007/s10549-004-1288-x. Breast Cancer Res Treat. 2005. PMID: 15770520 Free article. No abstract available.

6

GREB 1 is a critical regulator of hormone dependent breast cancer growth.

Rae JM, Johnson MD, Scheys JO, Cordero KE, Larios JM, Lippman ME. Rae JM, et al. Breast Cancer Res Treat. 2005 Jul;92(2):141-9. doi: 10.1007/s10549-005-1483-4. Breast Cancer Res Treat. 2005. PMID: 15986123 Free article.

7

CYP2D6 genotype and tamoxifen response.

Rae JM, Goetz MP, Hayes DF, Ingle JN, Li L, Storniolo AM, Stearns V, Flockhart DA. Rae JM, et al. Breast Cancer Res. 2005 Jul 29;7(5):E6. doi: 10.1186/bcr1297. Breast Cancer Res. 2005. PMID: 16168100 Free PMC article. No abstract available.

8

What does an orphan G-protein-coupled receptor have to do with estrogen?

Rae JM, Johnson MD. Rae JM, et al. Breast Cancer Res. 2005;7(6):243-4. doi: 10.1186/bcr1330. Epub 2005 Sep 29. Breast Cancer Res. 2005. PMID: 16280047 Free PMC article.

9

Combination vinorelbine and capecitabine for metastatic breast cancer using a non-body surface area dosing scheme.

Schott AF, Rae JM, Griffith KA, Hayes DF, Sterns V, Baker LH. Schott AF, et al. Among authors: rae jm. Cancer Chemother Pharmacol. 2006 Jul;58(1):129-35. doi: 10.1007/s00280-005-0132-2. Epub 2005 Nov 8. Cancer Chemother Pharmacol. 2006. PMID: 16283312 Free article. Clinical Trial.

10

GREB1 is a novel androgen-regulated gene required for prostate cancer growth.

Rae JM, Johnson MD, Cordero KE, Scheys JO, Larios JM, Gottardis MM, Pienta KJ, Lippman ME. Rae JM, et al. Prostate. 2006 Jun 1;66(8):886-94. doi: 10.1002/pros.20403. Prostate. 2006. PMID: 16496412

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters